Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.39 |
| ▸ | GAA | P10253 | 6/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.36 |
| ▸ | TSHR | P16473 | 4/20 | 0.36 |
| ▸ | MEN1 | O00255 | 3/20 | 0.36 |
| ▸ | LMNA | P02545 | 3/20 | 0.36 |
| ▸ | MAOB | P27338 | 2/20 | 0.36 |
| ▸ | MAOA | P21397 | 1/20 | 0.36 |
| ▸ | ACHE | P22303 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.35 |
| ▸ | BLM | P54132 | 2/20 | 0.35 |
| ▸ | ATM | Q13315 | 2/20 | 0.35 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.35 |
| ▸ | GMNN | O75496 | 1/20 | 0.35 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17877396 | 1.00 | ALDH1A1 (0.39) | ALDH1A1GAAKDM4EKMT2ATSHR | |
| SCHEMBL17877397 | 0.90 | MEN1 (0.33) | ALDH1A1GAAKDM4EKMT2ATSHR | |
| SCHEMBL18539827 | 0.89 | — | — | |
| SCHEMBL20000741 | 0.88 | ALDH1A1 (0.41) | ALDH1A1GAAKDM4EKMT2ATSHR | |
| SCHEMBL17877411 | 0.85 | POLB (0.32) | KMT2AMEN1POLB | |
| SCHEMBL17877398 | 0.85 | KMT2A (0.34) | ALDH1A1GAAKDM4EKMT2ATSHR | |
| SCHEMBL19677860 | 0.82 | ALDH1A1 (0.51) | ALDH1A1GAAKDM4EKMT2ATSHR | |
| SCHEMBL17881252 | 0.82 | CA1 (0.36) | ALDH1A1GAAKDM4EALOX15MAPT | |
| SCHEMBL17877414 | 0.81 | GAA (0.45) | ALDH1A1GAAKDM4EKMT2ATSHR | |
| SCHEMBL17877399 | 0.81 | HMGCR (0.38) | ALDH1A1GAAKDM4EKMT2ATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10018875-B2 | Curved liquid crystal display and method of manufacturing the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-07-10 | — | — | US | disclosed |
| US-10018875-B2 | Curved liquid crystal display and method of manufacturing the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-07-10 | — | — | US | disclosed |
| US-20180086981-A1 | LIQUID CRYSTAL COMPOSITION AND DISPLAY DEVICE INCLUDING THE SAME | TCL CHINA STAR OPTOELECTRONICS TECHNOLOGY CO., LTD. (CN) | 2018-03-29 | — | — | US | disclosed |
| US-20170052412-A1 | CURVED LIQUID CRYSTAL DISPLAY AND METHOD OF MANUFACTURING THE SAME | TCL CHINA STAR OPTOELECTRONICS TECHNOLOGY CO., LTD. (CN) | 2017-02-23 | — | — | US | disclosed |
| US-20170052412-A1 | CURVED LIQUID CRYSTAL DISPLAY AND METHOD OF MANUFACTURING THE SAME | TCL CHINA STAR OPTOELECTRONICS TECHNOLOGY CO., LTD. (CN) | 2017-02-23 | — | — | US | disclosed |
| US-20170038642-A1 | ALIGNMENT LAYER AND LIQUID CRYSTAL DISPLAY INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-02-09 | — | — | US | disclosed |
| US-20170038642-A1 | ALIGNMENT LAYER AND LIQUID CRYSTAL DISPLAY INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-02-09 | — | — | US | disclosed |
| US-20160185763-A1 | LIQUID CRYSTAL STABILIZER, LIQUID CRYSTAL COMPOSITION INCLUDING THE SAME, AND LIQUID CRYSTAL DISPLAY INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-06-30 | — | — | US | disclosed |
| US-20160185763-A1 | LIQUID CRYSTAL STABILIZER, LIQUID CRYSTAL COMPOSITION INCLUDING THE SAME, AND LIQUID CRYSTAL DISPLAY INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-06-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180086981-A1 | LIQUID CRYSTAL COMPOSITION AND DISPLAY DEVICE INCLUDING THE SAME | CNOT1, CXCR1, CCRL2 | ALDH1A1 309/4885GAA 4709/4885KDM4E 1824/4885 |
| US-20160185763-A1 | LIQUID CRYSTAL STABILIZER, LIQUID CRYSTAL COMPOSITION INCLUDING THE SAME, AND LIQUID CRYSTAL DISPLAY INCLUDING THE SAME | PYM1, YBX3, MLX | ALDH1A1 2589/4885GAA 4819/4885KDM4E 1512/4885 |
| US-10018875-B2 | Curved liquid crystal display and method of manufacturing the same | PDCD2L, VCL, LAS1L | ALDH1A1 2364/4885GAA 2818/4885KDM4E 3436/4885 |
| US-20170052412-A1 | CURVED LIQUID CRYSTAL DISPLAY AND METHOD OF MANUFACTURING THE SAME | PDCD2L, VCL, LAS1L | ALDH1A1 2364/4885GAA 2818/4885KDM4E 3436/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.